title: [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
abstract: OBJECTIVE
  To investigate the diagnosis, treatment and prognosis of recurrent epithelial ovarian carcinoma.
  
  
  METHODS
  Fifty-two patients with recurrent epithelial ovarian carcinoma who were admitted in Zhongnan Hospital of Wuhan University between 1997 and 2002 were analyzed retrospectively, and their diagnostic methods and the survival rates were compared.
  
  
  RESULTS
  The positive diagnostic rate of pelvic examination, CA(125) and ultrasound examination was 73.1%, 84.6% and 53.8%, respectively to the recurrent epithelial ovarian carcinoma. The median survival time of group A (surgery + chemotherapy) and group B (chemotherapy) was 11 and 12 months, respectively.
  
  
  CONCLUSIONS
  The diagnostic methods should include pelvic examination, CA(125) and ultrasound examination. We could not know the exact role of surgery to the management and prognosis of recurrent epithelial ovarian carcinoma. Chemotherapy may have an important role to the management and prognosis of recurrent epithelial ovarian carcinoma.
authors.affiliation: Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
authors.forename: Xu-feng
authors.initials: XF
authors.lastname: Wu
authors.forename: Hui-zhen
authors.initials: HZ
authors.lastname: Chen
authors.forename: Ding-fen
authors.initials: DF
authors.lastname: Han
mesh_terms: D000328:Adult; D018394:CA-125 Antigen / Q000097:blood; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed
chemical_list: D018394:CA-125 Antigen